Article ID Journal Published Year Pages File Type
2113102 Cancer Letters 2013 10 Pages PDF
Abstract

Growing evidence indicates that some tumor suppressive miRNAs are subject to epigenetic modifications during carcinogenesis. Here, we found that a large miRNA cluster of C19MC was upregulated in HCC cells after combined treatment with DNA methylation inhibitor and histone deacetylase inhibitor. MiR-517a and miR-517c were strikingly different from the remaining 41 miRNAs in C19MC. Ectopic expression of MiR-517a and miR-517c inhibited cell proliferation by blocking G2/M transition, whereas down-regulation of miR-517a and miR-517c facilitated cell growth. We further showed Pyk2 is a target of miR-517a and miR-517c and both the miRNAs are downregulated in HCC samples. These data collectively suggest that down-regulation of both miR-517a and miR-517c contribute to HCC development through regulating Pyk2.

► Human microRNA microarray analysis was performed on 8 HCC cell lines treated by DNA demethylation agent and histone deacetylase inhibitor. ► The largest human miRNA gene cluster C19MC on chromosome 19 was triggered by these epigenetic modification agents. ► Functional screen of 43 miRNAs on C19MC revealed that both miR-517a and miR-517c can suppress HCC cell growth. ► Both miR-517a and miR-517c inhibited cell proliferation by blocking G2/M transition. ► PYK2 is a target of both miR-517a and miR-517c.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , ,